Back to Search
MARY FERRANTI, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1205413192Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (3)
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
PMID 19036082·Br J Haematol·2009
4-observational
Serum C-reactive protein at diagnosis and response to therapy is the most powerful factor predicting outcome of multiple myeloma treated with thalidomide/ anthracycline-based therapy.
PMID 18854284·Clin Lymphoma Myeloma·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST
PHILADELPHIA, PA 19104 - Phone
- (215) 662-2200
Quick Facts
- NPI
- 1205413192
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 3
Are you this provider?
Claim Your Profile